Avalon Investment & Advisory Organon & Co. Transaction History

Avalon Investment & Advisory

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $1.89 Million - $2.44 Million	-65,828 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$28.63 - $35.64 $476,660 - $593,370	-16,649 Reduced 20.19%	65,828 $2.16 Million
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $2.35 Million - $3.13 Million	82,477 New	82,477 $2.5 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.